FDA Approves First Treatment for Patients with Plasminogen Deficiency, a Rare Genetic Disorder | FDA News
For Immediate Release: June 04, 2021 Today, the U.S. Food and Drug Administration approved Ryplazim (plasminogen, human-tmvh) for the treatment of patients with plasminogen deficiency type 1, also referred to…